Virus inactivation in red blood cell concentrates (RBCC) is being studied in order to increase the safety of the blood supply. For this purpose we have been studying the silicon phthalocyanine (Pc 4), a photosensitizer activated with red light. Two approaches were used to achieve enhanced selectivity of Pc 4 for virus inactivation. One was formulation of Pc 4 in liposomes that reduce its binding to red cells. The other was the use of a light emitting diode (LED) array emitting at 700 nm. Vesicular stomatitis virus (VSV) infectivity served as an endpoint for virus kill in treated RBCC. Red cell hemolysis and circulatory survival in rabbits served as measures for red cell damage. Treatment of small aliquots of human RBCC with 2 M Pc 4 in liposomes and 10 J/cm 2 of 700 nm LED light in the presence of the quenchers of reactive oxygen species glutathione and trolox resulted in 6 log 10 inactivation of VSV. Under these conditions hemolysis of treated red cells stored at 4°C for 21 days was only slightly above that of control cells. Rabbit RBCC similarly treated circulated with a half life of 7.5 days compared with 10.5 days of control. It is concluded that Pc 4 used as described here may be useful for viral decontamination of RBCC, pending toxicological and clinical studies. © 1999 
INTRODUCTION
Improvements in current practices of viral marker screening and donor self-exclusion are continuously increasing the safety of the blood supply. However, a risk of transmission of pathogens with the transfusion of cellular components of blood remains. [1] [2] [3] The implementation of sterilization procedures for red cell concentrates (RBCCs) and platelet concentrates holds the promise of eliminating pathogen transmission while diminishing the need for new screening tests for rarely occurring or as yet unknown transfusion transmissible pathogens. Various approaches have been used to sterilize blood cells, the most efficacious so far use photochemical methods. 4, 5 For sterilization of RBCC we have been studying the phthalocyanines, which are activated by light in the far red (660-700 nm). 6, 7 The silicon phthalocyanine (Pc 4) has been proven to be most effective for inactivation of HIV in its multiple forms. 8 However, because Pc 4 and other phthalocyanines target the lipid envelope of the viruses and can, therefore, cause red cell damage, we have used quenchers of reactive oxygen species to prevent some of this damage. 9, 10 The use of high irradiance 11 and an appropriate delivery vehicle 12 also improved the specificity of red cell sterilization by Pc 4. The mechanism of virus inactivation by Pc 4 has been studied and appears to involve damage to a variety of viral components. 13 In this paper we describe the use of Pc 4 formulated in liposomes and light emitting diode (LED) array operating at 700 nm as additional ways of achieving virus inactivation with concomitantly reduced damage to red cells. Using the combined approaches it is shown that under virucidal treatment conditions of RBCC, human red cells can be stored for at least 3 weeks with minimal hemolysis and the circulatory half life of rabbit red cells is reduced by about 30%.
were obtained from Avanti Polar Lipids, Inc. (Alabaster, AL). All other reagents were of the highest purity available commercially.
PREPARATION OF PC 4 IN LIPOSOMES
The following procedure describes preparation of Pc 4 in liposomes composed of phosphatidyl choline and phosphatidyl serine. The same procedure was used to prepare Pc 4 in liposomes of various other compositions. Pc 4 (1 mg) was dissolved in 0.5 ml of N-methylpyrrolidone prewarmed to 50°C and sonicated 1-2 min. 1-palmitoyl-2-oleoyl-snglycero-phosphocholine (POPC) was dissolved (90 mg in 0.5 ml) in tert-butyl alcohol, prewarmed to 50°C. Similarly, 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS) was dissolved (10 mg in 0.5 ml). The solutions were sonicated at 50°C until complete dissolution occurred. The phospholipid solutions were combined and kept at 50°C. The Pc 4 solution was combined with the phospholipid solution at 50°C to achieve a ratio of Pc4:phospholipid ϭ1:100 (w/w). This was mixed with excess (16ϫ) of aqueous solution containing 9.45% D-lactose and 0.027% NaCl. Prior to mixing, the organic solution should be at 50°C and the aqueous solution at 4°C. The former is added dropwise into the latter with vigorous stirring. Stirring was continued for 15 min at 4°C. The resulting liposomal suspension was concentrated (10ϫ) with 100 Da Amicon concentrator and centrifuged at 3000 rpm at room temperature. The remaining organic solvents were removed by dialysis against lactose/NaCl solution at 4°C using a dialysis membrane with a molecular weight (MW) cutoff at 6000-8000. The dialysis solution was changed 3ϫ every few hours. High pressure liquid chromatography (HPLC) analysis detected no residual organic solvent at the conclusion of the dialysis. Due to its lipophilic nature, all of the added Pc 4 was incorporated in the liposome membrane. The final liposomal solution of Pc 4 was lyophilized and stored at 4°C. Prior to use, the liposomes were dissolved in phosphate buffered saline (PBS) using a vortex for mixing followed by 1-2 min of sonication. In some experiments, the following lipids were included in the composition of the liposomes:
1,2-dioleolyl-sn-glycero-3-phosphate (PA); 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC); 1,2-distearly-sn-glycero-3-[phospho-rac-(1-glycerol)] sodium salt (DSPG); 1,2-distearyl-snglycero-3-phosphocholine (DSPC); cholesterol (chol) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine-N-[poly(ethylene glycol) 5000] (PEG). Upon rehydration, the resulting liposome suspension was evaluated with transmission electron microscopy. The average liposome size was 50 nm.
PHOTODYNAMIC TREATMENT OF RBCC
RBCC samples (3 ml in 10 ml polystyrene tubes) at hematocrit of 58%-60% in Adsol, obtained from Blood Services, The New York Blood Center, were irradiated with red light either as a broadband (600-800 nm) or as a narrow band at 668 or 700 nm. Broadband light was from a 300 W xenon short arc lamp (Oriel Corp., Stratford, CT) equipped with a cutoff filter (Ͼ600 nm) with an irradiance of 25 mW/cm 2 . Narrow band light (27 nm bandwidth at half height) was from LED arrays (Efos Canada, Inc., Mississauga, Ontario, Canada) emitting at either 668 or 700 nm with an irradiance of 50 mW/cm 2 . During irradiation the samples were rotated and rolled on a hematology mixer (Fisher Scientific, Inc., Pittsburgh, PA) to obtain even exposure. Temperature was kept at 25 or 4°C by an air stream of appropriate temperature.
VIRUS INACTIVATION
Inactivation of vesicular stomatitis virus (VSV) in RBCC was studied using a standard virus infectivity assay. 8 VSV was initially obtained from Dr. W. Stewart (Sloan Kettering Memorial Hospital, New York, NY) and was cultured in human A549 cells. Prior to photodynamic treatment, RBCC samples were spiked with 10 7 infectious units per ml together with Pc 4 at 2 M final concentration and the quenchers glutathione and trolox at 4 and 5 mM, respectively. After treatment, samples of 0.3 ml were diluted tenfold with Dulbecco's modified Eagle's medium containing 5% fetal calf serum for further processing, and centrifuged at 1900 rpm for 5 min to remove the red cells. The supernatants were sterile filtered using 0.22 m filters (Millipore, Bedford, MA) and either stored at −80°C or assayed immediately for virus infectivity. This processing removed most of the Pc 4 prior to assay. However, in control experiments the presence of Pc 4 did not interfere with viral assay. No loss of virus titer occurred as a result of the processing and sterile filtration.
PC 4 ANALYSIS IN RBCC
The amount of Pc 4 bound to RBC and Pc 4 in the plasma was measured using HPLC and extraction procedures described previously. 15 Briefly, acetonitrile extracts were purified with reversed-phase Sep-Pak C 18 cartridges and Pc 4 was determined in the extracts by HPLC using a reversed-phase C 18 column and a mobile phase consisting of 10% H 2 O and 1% CH 3 COOH in methanol. The detection limit of Pc 4 is 2 ng/ml. The amount of Pc 4 was expressed as percentage of the total recovered in RBCC. Recovery of Pc 4 was about 90% (Ϯ10%).
RBC HEMOLYSIS
Samples of RBCC were stored after treatment at 4°C without further processing. The extent of hemolysis was determined by comparing the hemoglobin in the supernatant to the total hemoglobin. The total hemoglobin was determined by using the Drabkin reagent (Sigma Procedure No. 525, Sigma Chemical Co., St. Louis, MO). The absorption at 540 nm was used to calculate the amount of hemoglobin released in the supernatant, assuming an absorbance of 0.86 for 1 mg hemoglobin per ml.
CIRCULATORY SURVIVAL OF RBC
Rabbit RBCCs were treated as described for human red cells and their circulatory survival was determined as described previously. 9 Briefly, treated red cells were labeled with 1Ci/ml Na 2
51
CrO 4 for 1 h at room temperature and then thoroughly washed 5ϫ with PBS. The labeled cells were infused autologously. At intervals of 1 h, 24 h, and 3, 7, 10, and 13 days after infusion, 1 ml blood was withdrawn and the radioactivity associated with RBC was determined, using a liquid scintillation counter. Each datum point is for a single animal. The control, untreated RBC, gave the same results in several experiments ͓nϭ3, standard error of the mean (SEM) Ϯ0.5 day].
RESULTS
The usefulness of liposomes as a delivery vehicle for Pc 4 as a photosensitizer for inactivation of lipid-enveloped viruses in RBCC was assessed using VSV as a model virus. Figure 1 shows that the rate of inactivation of VSV does not depend on time of incubation of liposomal Pc 4 prior to light exposure and that it is similar to that obtained when Pc 4 is delivered in an organic solvent dimethyl sulfoxide (DMSO) or in a detergent-like agent (Cremophor). However, binding of Pc 4 to red cells does depend on the delivery vehicle and, in the case of liposomes, on the preirradiation incubation time (Table 1) . These results suggested that exposure to light after short incubation times with liposomal Pc 4 should result in less damage to red cells. Figure 2 shows this is indeed the case. Treated red cells were stored and their hemolysis followed and, as expected from the binding studies, formulation of Pc 4 in liposomes resulted in reduced hemolysis, and incubation of liposomal Pc 4 for 5 min prior to irradiation resulted in less hemolysis than incubation for 30 min.
The effect of the liposome composition on Pc 4 binding to red cells is shown in Table 2 . There were large differences in binding depending on composition. Compositions containing PEG or cholesterol displayed greatly enhanced binding. This was also reflected in greatly enhanced hemolysis of red cells (55% and 83%, respectively, after 7 days' storage). Tables 1 and 2 shows that with POPC:DOPSϭ9:1 at room temperature there is more binding to RBC than at 4°C. VSV kill was not affected by the incubation temperature (data not shown). Liposomal compositions showing reduced Pc 4 binding to red cells were compared with respect to VSV inactivation (Figure 3) . There was about a twofold difference in the dose required for complete virus kill (5 log 10 ), 5-12 J/cm 2 . For each liposomal preparation tested in Figure 3 , an equivirucidal light dose resulting in complete VSV kill was used to test for RBC damage. The treated RBCCs were stored after treatment and hemolysis followed over time. The results (Figure 4 ) show great differences in the ability of equivirucidal doses to cause RBC damage, depending on the liposome composition. Since POPC:DOPSϭ4:1 resulted in the least RBC damage, this composition was chosen for further studies.
Comparison of
In further studies, LED arrays emitting at either 668 or 700 nm were compared. Figure 5 shows that both light sources were equally effective for inactivation of VSV. However, when RBCCs were treated with 10 J/cm 2 from either light source and then stored at 4°C, hemolysis developed in samples treated with 668 nm LED much faster than in those treated with 700 nm LED (Figure 6 ). In the latter, the rate of hemolysis was only slightly faster than in control, untreated RBCC.
The ability of treated RBC to circulate in vivo was tested in rabbits and in baboons. Some reduction of the circulatory half life was observed, from 10.5 days in control to 7.5 days after treatment with 10 J/cm 2 ( Figure 7) . In preliminary studies in baboons, whose RBC are more similar to those of humans, treatment with liposomal Pc 4 and 10 J/cm 2 of 700 nm light had only a slight effect on the circulatory half life, reducing it from 13.2 to 11.6 days (not shown). It should be noted that 24 h recovery in vivo of the treated RBC always exceeded 90%.
DISCUSSION
In this work, enhancement of the specificity of Pc 4 for virus inactivation in RBCC was studied using two different approaches. First, we formulated Pc 4 in liposomes and optimized the liposomes composition so that binding of Pc 4 to red cells was minimized while maintaining good virus kill. Second, we selected as a light source LED array emitting a narrow band at 700 nm, corresponding to the spectrum region where Pc 4-induced red cell damage is minimal and virus kill is significant. 16 When we combined the two approaches, hemolysis following a virucidal light dose (10 J/cm 2 ) did not exceed 1% over 3 weeks storage and circulatory half life and 24 h recovery of fresh cells which had been treated were improved.
With regard to the liposome composition, a specific feature that makes liposomes optimal for delivery of Pc 4 has not been identified. Thus, attaching PEG and producing ''stealth'' liposomes, an approach used to prevent removal of liposomes by the reticuloendothelial system, 17 enhanced Pc 4 binding to red cells (Table 2) , and resulted in massive hemolysis. Incorporation of cholesterol in the liposomes resulted in even higher Pc 4 binding to red cells. Liposomes composed of the synthetic phospholipids POPC and DOPS gave optimal results. Interestingly, although increasing the ratio of the charged moiety DOPS from 9:1 to 1:1 resulted in progressively reduced binding of Pc 4 to red cells (Table 2) , minimal hemolysis was obtained with a ratio of 4:1 (Figure 4) . The reasons for this apparent discrepancy are not known. One possibility could be a greater lability of the more negatively charged liposomes to photodynamic degradation during light exposure. The Pc 4 released would be available for binding to red cells. Greater lability could result from the presence of two oleic acid moieties in DOPS compared to one in POPC. Unsaturated fatty acids are more prone to oxidative damage than saturated ones. It is possible that liposomes of a composition not tested in our studies may prove even better than the one we selected to deliver Pc 4 into RBCC. However, in the absence of a clear guideline, improving the current composition is a matter of trial and error.
It is worthy of note that virucidal treatment (10 J/cm 2 of 700 nm light) which reduced the circulatory survival of rabbit red cells by about 30% (Figure 7) had only a slight effect on baboon red cells. This is not surprising since rabbit red cells are more susceptible than primate red cells, as observed by us before using another phthalocyanine photosensitizer. 9, 18 While our results are promising, a note of caution is in order. The process has so far been shown to be effective only against lipid-enveloped viruses, and in small volumes of RBCC only. More tests on RBC during storage need to be done such as K + leakage and ATP levels, as well as lipid peroxidation and protein modification. We also envisage removing Pc 4 after treatment, even though toxicological studies show that it possesses a favorable toxico- logical profile (studies by the National Cancer Institute).
